Lilly Drops CVS Drug Plan for Workers After Novo Deal

Eli Lilly & Co. Zepbound injection pens.

Photographer: Shelby Knowles/Bloomberg

Eli Lilly & Co. is dropping CVS Health Corp’s drug benefit plan for its employees after CVS stopped covering its blockbuster weight-loss drug in favor of a rival medication from Novo Nordisk A/S, according to people familiar with the matter.

Starting on Jan. 1, Lilly employees covered by the company’s medical plan will automatically be enrolled with pharmacy benefit coverage through Rightway, a privately held pharmacy benefit manager, according to a document viewed by Bloomberg.